Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Harriet Ho
Biomarkers and Outcomes in Omalizumab-Treated Patients With Allergic Asthma: A Real-World Study in a Large Allergy Practice in the United States (US)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Long-Term Outcomes of Omalizumab in Chronic Idiopathic Urticaria (CIU): Evidence From a Large Allergy Practice in the United States (US)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab Treatment Patterns in Chronic Idiopathic Urticaria (CIU): Evidence From a Large Allergy Practice in the United States (US)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab Gets Tolerance in Patients With Severe Food Allergy: A Real-Life Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Establishing the Relationship of Inhaler Satisfaction, Adherence, Smoking History and Allergic Rhinitis With Patient Outcomes: Real World Observations in US Adult Asthma Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effects of Omalizumab on Blood Eosinophil Numbers in Patients With Allergic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Demographic Characteristics, Comorbidities, and Exacerbation Frequency Among Patients Enrolled in the Chronicle Study: A Real-World, Prospective, Observational Study of US, Subspecialist-Treated Adults With Severe Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Omalizumab: A Potential Therapy Option for Allergic Bronchopulmonary Aspergillosis (ABPA) in Asthma Patients
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Reduced Asthma Exacerbations and Asthma-Related Healthcare Resource Use With Omalizumab From the Real-World PROSPERO Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Characteristics and Outcomes of Patients Treated With Apremilast in the Real World: Results From the APPRECIATE Study
Journal of the European Academy of Dermatology and Venereology
Dermatology
Infectious Diseases
